Literature DB >> 2918997

Effects of melatonin on neuronal activity in the rat suprachiasmatic nucleus in vitro.

S Shibata1, V M Cassone, R Y Moore.   

Abstract

The pineal hormone melatonin is believed to act directly on the hypothalamic suprachiasmatic nuclei (SCN), which are principal circadian pacemakers in rodents, although direct demonstration of this is lacking. To determine whether the SCN are sensitive to melatonin electrophysiologically, we investigated the effect of melatonin on rat SCN single-unit activity in an in vitro hypothalamic slice preparation. SCN single-unit activity was inhibited by melatonin superfusion during the late subjective day in a dose-dependent manner but not at other times of day, supporting the view that melatonin acts directly on SCN neurons.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2918997     DOI: 10.1016/0304-3940(89)90153-5

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  14 in total

1.  Orphanin-FQ/nociceptin (OFQ/N) modulates the activity of suprachiasmatic nucleus neurons.

Authors:  C N Allen; Z G Jiang; K Teshima; T Darland; M Ikeda; C S Nelson; D I Quigley; T Yoshioka; R G Allen; M A Rea; D K Grandy
Journal:  J Neurosci       Date:  1999-03-15       Impact factor: 6.167

Review 2.  Understanding melatonin receptor pharmacology: latest insights from mouse models, and their relevance to human disease.

Authors:  Gianluca Tosini; Sharon Owino; Jean-Luc Guillaume; Ralf Jockers
Journal:  Bioessays       Date:  2014-06-05       Impact factor: 4.345

3.  BIOLOGICAL TIMEKEEPING.

Authors:  Martha U Gillette; Sabra M Abbott
Journal:  Sleep Med Clin       Date:  2009-06-01

4.  Ramelteon prior to a short evening nap impairs neurobehavioral performance for up to 12 hours after awakening.

Authors:  Daniel A Cohen; Wei Wang; Elizabeth B Klerman; Shantha M W Rajaratnam
Journal:  J Clin Sleep Med       Date:  2010-12-15       Impact factor: 4.062

Review 5.  Functional MT1 and MT2 melatonin receptors in mammals.

Authors:  Margarita L Dubocovich; Magdalena Markowska
Journal:  Endocrine       Date:  2005-07       Impact factor: 3.633

6.  International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors.

Authors:  Margarita L Dubocovich; Philippe Delagrange; Diana N Krause; David Sugden; Daniel P Cardinali; James Olcese
Journal:  Pharmacol Rev       Date:  2010-07-06       Impact factor: 25.468

7.  Modulation of intercellular calcium signaling by melatonin in avian and mammalian astrocytes is brain region-specific.

Authors:  Jennifer L Peters; Barbara J Earnest; Ronald B Tjalkens; Vincent M Cassone; Mark J Zoran
Journal:  J Comp Neurol       Date:  2005-12-19       Impact factor: 3.215

8.  Melatonin inhibits hippocampal long-term potentiation.

Authors:  Louisa M Wang; Nanthia A Suthana; Dipesh Chaudhury; David R Weaver; Christopher S Colwell
Journal:  Eur J Neurosci       Date:  2005-11       Impact factor: 3.386

9.  Randomized controlled trial of pharmacological replacement of melatonin for sleep disruption in individuals with tetraplegia.

Authors:  Jamie M Zeitzer; Ban Ku; Doug Ota; B Jenny Kiratli
Journal:  J Spinal Cord Med       Date:  2013-10-24       Impact factor: 1.985

10.  Melatonin modulates the light-induced sympathoexcitation and vagal suppression with participation of the suprachiasmatic nucleus in mice.

Authors:  Tatsushi Mutoh; Shigenobu Shibata; Horst-Werner Korf; Hitoshi Okamura
Journal:  J Physiol       Date:  2003-01-10       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.